Scott Sherman
Scott Sherman, MD, MPH
NYU Langone Health - Professor of Population Health, Medicine and Psychiatry
NYU College of Global Public Health - Professor of Global Public Health
NYU Langone Health - Co-Chief, Section on Tobacco, Alcohol and Drug Use, Department of Population Health
MD, Medicine, New York University School of Medicine
MPH, Epidemiology & Biostatistics, Boston University School of Public Health
AB, Mathematics, Brown University
Research Interests
Smoking cessation, Alternative tobacco products, Substance abuse/dependence, Health services research, Implementation research
After receiving his MD from NYU School of Medicine, Scott Sherman completed a residency in Primary Care Internal Medicine at Bellevue Hospital and then a research fellowship in General Internal Medicine at Boston University. Dr. Sherman joined the faculty at University of California, Los Angeles in 1991 and was a staff physician for the Veterans Health Administration (VA). In 2005, he transferred back to New York City, where he is currently Professor of Population Health, Medicine and Psychiatry at NYU School of Medicine and Co-Chief of the Section of Tobacco, Alcohol and Drug Use. Dr. Sherman’s main area of interest is how to redesign health care systems to better help people quit smoking. He is particularly focused on Translational Studies, which examine the effectiveness of interventions in routine practice, as well as how to disseminate and implement them. Dr. Sherman is currently PI/MPI of seven major grants: 1) a mid-career mentoring award (K24 – NIH/NIDA), 2) A behavioral economic intervention to improve psychiatrist adherence to tobacco treatment guidelines (R34 – NIDA), 3) Integrating Financial Management and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants (Robin Hood Foundation) 4) Center for Alternative Tobacco Product Studies (New York State), 5) Text messaging to engage and retain Veterans in smoking cessation counseling (VA Health Services Research and Development Service), 6) Comparing an opt-out to an opt-in approach for smoking cessation in VA primary care clinics (VA Health Services Research and Development Service), and 7) NYU/Abu Dhabi Public Health Research Center.
Principal Investigator, A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings. Active
Principal Investigator, Behavioral Economic Intervention to Improve Psychiatrist Adherence to Tobacco Treatment Guidelines. Active
Principal Investigator, Comparing an Opt-Out to an Opt-In Approach for Smoking Cessation In VA Primary Care Clinics. Active
Principal Investigator, Financial Incentive Strategies for Smoking Cessation in High-Risk Hospitalized Patients. Active
Principal Investigator, Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling. Active
Principal Investigator, Assessing Use of Alternative Tobacco Products Among Students at City University of New York (CUNY). Completed
Principal Investigator, Center for Alternative Tobacco Product Studies. Completed
Principal Investigator, Effectiveness of Smoking-Cessation Interventions for Urban Hospital Patients. Completed
Principal Investigator, Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants. Completed
Principal Investigator, Midcareer Investigator Award in Patient-Oriented Research. Completed
Principal Investigator, NYU/Abu Dhabi Public Health Research Center. Completed
Principal Investigator, Proactive Outreach for Smokers in VA Mental Health. Completed


Palamar JJ, Acosta P, Cleland CM, Sherman S (2021).
Reliability of a rapid screener for an intercept survey about drug use
Substance Use and Misuse, 56 (12), 1831-1836. doi: 10.1080/10826084.2021.1954029. PMCID: PMC8478894.

Hammett PJ, Businelle MS, Taylor BC, Erbes CR, Bastian L, Doran N, Sherman SE, Rogers ES, Burgess DJ, Fu SS (2021).
The association between smoking abstinence and pain trajectory among veterans engaged in VA mental health care
Pain Medicine, 22 (8), 1793-1803. doi: 10.1093/pm/pnab009.

Brake L, Myrie A, Zhao C, Feuer Z, Taylor J, Bjurlin MA, Sherman SE, Makarov DV, Matulewicz RS (2021).
Population-level assessment of smoking-related beliefs and behaviors among survivors of genitourinary cancers: An application of the Theory of Planned Behavior
Urology, 154, 215-220. doi: 10.1016/j.urology.2021.01.048..

Enkema MC, Hasin DS, Browne KC, Stohl M, Shmulewitz D, Fink DS, Olfson M, Martins SS, Bohnert KM, Sherman SE, Cerda M, Wall M, Aharonovich E, Keyhani S, Saxon AJ (2021).
Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III
Pain [Epub 2021 May 26]. doi: 10.1097/j.pain.0000000000002345.

Bernstein AP, Bjurlin MA, Sherman SE, Makarov DV, Rogers E, Matulewicz RS (2021).
Tobacco screening and treatment during outpatient urology office visits in the United States
Journal of Urology, 205 (6), 1755-1761. doi: 10.1097/JU.0000000000001572.


Sherman S (2008).
A framework for tobacco control: lessons learnt from Veterans Health Administration
BMJ, 336, 1016-1019. doi: 10.1136/bmj.39510.805266.BE. PMCID: PMC2364861.

Dr. Sherman's MyBibliography Profile